India to Sudan: Artemether Export Trade Route
India has recorded 314 verified shipments of Artemether exported to Sudan, representing a combined trade value of $14.7M USD. This corridor is served by 51 active Indian exporters, with an average shipment value of $46.8K USD. The leading Indian exporter is INNOVA CAPTAB LIMITED, which accounts for 18% of total export value with 85 shipments worth $2.6M USD. On the buying side, FEDERAL MINISTRY OF HEALTH is the largest importer in Sudan with $2.0M USD in purchases. The top 3 suppliers — INNOVA CAPTAB LIMITED, AJANTA PHARMA LIMITED, LINCOLN PHARMACEUTICALS LTD — together control 45% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Sudan Artemether corridor is one of India's established pharmaceutical export routes, with 314 shipments documented worth a combined $14.7M USD. The route is dominated by INNOVA CAPTAB LIMITED, which alone accounts for roughly 18% of all export value, reflecting the consolidated nature of India's artemether manufacturing sector.
Across 51 active suppliers, the average shipment value stands at $46.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 29.7%, placing it at rank #1 among India's top artemether export destinations globally.
On the import side, key buyers of Indian artemether in Sudan include FEDERAL MINISTRY OF HEALTH, AMIPHARMA LABORATORIES LTD , ELWALIEF INTERNATIONAL FOR MULTI AC and 88 others. FEDERAL MINISTRY OF HEALTH is the single largest importer with 5 shipments valued at $2.0M USD.
